<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[GemPharmatech 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=40414></link><description><![CDATA[GemPharmatech 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Tue, 05 May 2026 11:48:06 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2022/04/12_1026003021_20220426154527_2871840020.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[GemPharmatech, Leading Provider of Genetically Engineered Mouse Models, Goes Public on Shanghai Stock Exchange]]></title><link>https://www.newswire.co.kr/newsRead.php?no=943452</link><description><![CDATA[WILMINGTON, Del.--(Business Wire/Korea Newswire)--GemPharmatech LLC is pleased to announce that on April 25, 2022, its parent company, GemPharmatech Co., Ltd., went public on the STAR MARKET of the Shanghai Stock Exchange under the stock code 688046. The initial offering included 50,000,000 ordinary shares at a public offering price of￥22.53 ($3.51) per share.  GemPharmatech, established on De...]]></description><pubDate>Tue, 26 Apr 2022 16:15:00 +0900</pubDate></item><item><title><![CDATA[유전자변형쥐 모델 공급업체 젬파마텍, 상하이 증시 상장]]></title><link>https://www.newswire.co.kr/newsRead.php?no=943454</link><description><![CDATA[윌밍턴, 델라웨어--(Business Wire/뉴스와이어)--젬파마텍 유한책임회사(GemPharmatech LLC)는 모회사 젬파마텍(GemPharmatech Co., Ltd.)이 2022년 4월 25일 상하이 증권거래소의 스타마켓(STAR MARKET)에 종목코드 688046으로 상장됐다고 발표했다.  초기 공모에는 보통주 5000만주가 포함됐으며 공모가는 주당 22.53엔(3.51달러)이었다.  2017년 12월 29일 설립된 젬파마텍은 실험용 동물 모델의 연구 개발, 생산, 기술 ...]]></description><image><url><![CDATA[https://file.newswire.co.kr/data/datafile2/thumb/2022/04/1026003021_20220426155916_4826741680.jpg]]></url></image><pubDate>Tue, 26 Apr 2022 16:15:00 +0900</pubDate></item></channel></rss>